# Federal Policy, DEA Rescheduling & Healthcare Economics > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/videos/federal-policy-dea-rescheduling/ > **Published:** 2026-10-08T19:32:55-04:00 | **Last Modified / Clinically Audited:** 2026-10-29T16:09:54-04:00 > **Clinical Summary:** Expert clinical analysis and congressional testimony from Dr. Benjamin Caplan on DEA Schedule III cannabis rescheduling and its healthcare economic impact. --- [Home](https://cedclinic.com/) / [Video Archive & Media Hub](https://cedclinic.com/videos/) / Federal Policy & DEA Rescheduling 🏛️ Federal Jurisprudence & Health Policy Table of Contents - [Federal Policy, DEA Rescheduling & Healthcare Economics](#Federal_Policy_DEA_Rescheduling_038_Healthcare_Economics)[Live From Washington: The Medical Marijuana Research Act Signed into Law](#Live_From_Washington_The_Medical_Marijuana_Research_Act_Signed_into_Law) - [Massachusetts 60-Day Rolling Supply Limit: Patient Protections](#Massachusetts_60-Day_Rolling_Supply_Limit_Patient_Protections) - [NBC Boston: Is It Time for Health Insurers to Cover Medical Marijuana?](#NBC_Boston_Is_It_Time_for_Health_Insurers_to_Cover_Medical_Marijuana) - [The 4 Core Battles in Federal Cannabis Reform](#The_4_Core_Battles_in_Federal_Cannabis_Reform)[🏛️ Schedule III vs. Real Patient Access](#_Schedule_III_vs_Real_Patient_Access) - [🛡️ Physician Recommendation Safe Harbors](#_Physician_Recommendation_Safe_Harbors) - [📊 Dismantling the Research Monopoly](#_Dismantling_the_Research_Monopoly) - [💰 Health Insurance & Payer Parity](#_Health_Insurance_038_Payer_Parity) - [Mass Medical Marijuana Online Registration: Step-by-Step Portal Walkthrough](#Mass_Medical_Marijuana_Online_Registration_Step-by-Step_Portal_Walkthrough) - [Explore Clinical & Media Investigations](#Explore_Clinical_038_Media_Investigations)[🎓 Doctor-to-Doctor Grand Rounds](#_Doctor-to-Doctor_Grand_Rounds) - [🌍 Voice of America International Feature](#_Voice_of_America_International_Feature) - [💊 Opioid-Sparing & Harm Reduction](#_Opioid-Sparing_038_Harm_Reduction) - [⭐ Montel Williams 3-Part Masterclass](#_Montel_Williams_3-Part_Masterclass) - [Need Guidance Navigating Medical Cannabis Laws & Care?](#Need_Guidance_Navigating_Medical_Cannabis_Laws_038_Care) - [60-Second Cannabis Policy, DEA & Law Reels](#60-Second_Cannabis_Policy_DEA_038_Law_Reels)[30 Seconds. One Ballot Question: A Major Change to Cannabis Policy](#30_Seconds_One_Ballot_Question_A_Major_Change_to_Cannabis_Policy) - [DEA Schedule III Rescheduling: What Actually Changes for Patients](#DEA_Schedule_III_Rescheduling_What_Actually_Changes_for_Patients) # Federal Policy, DEA Rescheduling & Healthcare Economics Expert clinical testimony before Congress and national news analysis: examining Schedule III reclassification, independent university trials under the Medical Marijuana Research Act, and the clinical case for health insurance parity. ⚖️ DEA Schedule III Analysis 📺 FOX 5 DC Live Broadcast 💳 NBC Boston Insurance Parity ● Featured Washington Broadcast FOX 5 DC Live • National Capital Region [▶ Watch Live FOX 5 DC Broadcast (Official Stream) ↗](http://www.fox5dc.com/video/1152953) ### Live From Washington: The Medical Marijuana Research Act Signed into Law Live on FOX 5 DC, Dr. Benjamin Caplan breaks down the historic passage of the bipartisan Medical Marijuana Research Act. For over fifty years, American academic researchers were legally restricted to utilizing low-grade, freeze-dried cannabis grown exclusively at the University of Mississippi—material bearing virtually zero resemblance to real-world dispensary chemovars. Dr. Caplan explains how licensing independent research universities transforms clinical discovery and dismantles decades of government monopoly. [Launch FOX 5 Video Stream ↗](http://www.fox5dc.com/video/1152953) [Read Federal Hearing Outline ↗](https://benjamincaplan.com/dr-caplan-to-testify-at-dea-rescheduling-hearings) 📜 State Law Patient Legal Rights & State Supply Limits ### Massachusetts 60-Day Rolling Supply Limit: Patient Protections Under Massachusetts Cannabis Control Commission (CCC) regulations, certified medical patients have legal authorization to purchase and possess up to a 60-day rolling supply (up to 10 ounces of cannabis or its equivalent in concentrates/infused products). Read Dr. Caplan’s definitive clinical breakdown of supply thresholds, hardship dispensations, and how certified patients are protected under state statutes. [Read Full Massachusetts 60-Day Supply Guide ↗](https://cedclinic.com/massachusetts-60-day-rolling-supply-limit-medical-cannabis-2026/) ● Healthcare Economics & Payer Parity NBC Boston In-Depth Special [▶ Watch NBC Boston Insurance Parity Report ↗](https://www.nbcboston.com/news/local/is-it-time-for-health-insurers-to-cover-medical-marijuana/3005331/) ### NBC Boston: Is It Time for Health Insurers to Cover Medical Marijuana? Why do commercial health insurers reimburse tens of thousands of dollars each month for addictive prescription opioids, synthetic hypnotics, and high-risk biologics, while forcing patients with chronic illness to pay entirely out-of-pocket for therapeutic cannabis? Dr. Benjamin Caplan joins NBC Boston’s investigative health desk to quantify systemic payer savings: when patients replace heavy polypharmacy with guided botanical regimens, emergency department admissions and adverse [drug interactions](https://cedclinic.com/cbd-gummies-pain-management/) drop dramatically. [Watch Full NBC Investigation ↗](https://www.nbcboston.com/news/local/is-it-time-for-health-insurers-to-cover-medical-marijuana/3005331/) [NBC: Curiosity is the Cure ↗](http://www.nbcboston.com/news/local/curiosity-is-the-cure-local-experts-discuss-hurdles-facing-cannabis-in-health-care/3007202/) Jurisprudential Analysis ## The 4 Core Battles in Federal Cannabis Reform Key clinical and regulatory priorities presented in Dr. Caplan’s administrative hearings and congressional testimony. DEA Rescheduling #### 🏛️ Schedule III vs. Real Patient Access Moving cannabis from Schedule I to Schedule III acknowledges its accepted medical use under federal law and eliminates IRS 280E taxation. However, Schedule III requires FDA-approved NDA/IND manufacturing pipelines—which would outlaw existing state-regulated dispensaries unless safe harbors protect state [patient access](https://cedclinic.com/tsa-rules-on-cbd-gummies-travel-guidelines-2026/). Clinician Protection #### 🛡️ Physician Recommendation Safe Harbors Under federal Schedule III rules, standard prescription requirements apply. Since botanical chemovars cannot be prescribed via typical pharmacy scripts, Dr. Caplan advocates for clear federal recognition of physician certifications modeled after Conant v. Walters. Clinical Evidence #### 📊 Dismantling the Research Monopoly For decades, the NIDA Mississippi monopoly restricted studies to sub-par, desiccated plant material. With the Medical Marijuana Research Act, independent academic universities can finally study the exact chemovars, terpenes, and extraction formats that patients consume. Healthcare Savings #### 💰 Health Insurance & Payer Parity Over 20% of chronic pain patients substitute cannabis for prescription opioids. When insurers refuse to cover clinician consultations or botanical medications, low-income patients are forced back onto addictive pharmaceuticals that carry 100% insurance coverage. 🏥 CCC Guide Official Patient Certification Portal ### Mass Medical Marijuana Online Registration: Step-by-Step Portal Walkthrough Looking to certify or renew your patient status with the Massachusetts Cannabis Control Commission? CĒD Clinic has compiled the complete step-by-step walkthrough covering physician PINs, residency verification, government identification, and same-day digital temporary card issuance. [Read Massachusetts Online Registration Guide ↗](https://cedclinic.com/mass-medical-marijuana-online-registration/) [Medical Cards MA Overview ↗](https://cedclinic.com/medical-cards-massachusetts/) Related Video Hubs & Clinical Archives ### Explore Clinical & Media Investigations #### 🎓 Doctor-to-Doctor Grand Rounds Harvard medical keynotes, pharmacology lectures, and physician-to-physician education on CYP450 metabolism and endocannabinoid science. [Watch Grand Rounds ↗](https://cedclinic.com/videos/doctor-grand-rounds-clinical-pharmacology/) #### 🌍 Voice of America International Feature Documentary profiling CĒD Clinic’s clinical care blueprint broadcast to 300M+ viewers in dozens of languages worldwide. [Watch VOA Documentary ↗](https://cedclinic.com/videos/voice-of-america-cannabis-documentary/) #### 💊 Opioid-Sparing & Harm Reduction 7News WHDH investigation into substituting botanical cannabis for lethal prescription narcotics and benzodiazepines. [Watch Harm Reduction ↗](https://cedclinic.com/videos/opioid-sparing-harm-reduction/) #### ⭐ Montel Williams 3-Part Masterclass Montel Williams & Dr. Caplan on navigating Multiple Sclerosis, chronic illness, and evidence-based dosing protocols. [Watch Montel Anthology ↗](https://cedclinic.com/videos/montel-williams-chronic-illness-ms/) Evidence-Based Compassionate Care ### Need Guidance Navigating Medical Cannabis Laws & Care? Whether you are seeking state-certified medical card protection in Massachusetts or individualized guidance for chronic pain, oncology recovery, or neurological disorders, CĒD Clinic provides comprehensive physician care. [Book Clinical Consultation ↗](https://cedclinic.com/contact-ced-staff/) [Explore Dr. Caplan’s Handbook ↗](https://www.DoctorApprovedCannabisHandbook.com) Federal Health Policy Reels ### 60-Second Cannabis Policy, DEA & Law Reels Translating federal rescheduling politics, ballot measures, and clinical research barriers into clear, plain English. [🎬 Explore All 137 Reels in Theater ↗](/videos/tiktok-clinical-education/) 60-Sec Reel 0:30 [▶](https://www.tiktok.com/@drbenjamincaplan/video/7691330524664646942) #### 30 Seconds. One Ballot Question: A Major Change to Cannabis Policy Dr. Caplan breaks down pivotal voter ballot initiatives and what changes—and what remains untouched—for medical patients and consumers. [♬ Watch on TikTok ↗](https://www.tiktok.com/@drbenjamincaplan/video/7691330524664646942) 60-Sec Reel 1:00 [▶](https://www.tiktok.com/@drbenjamincaplan/video/7577237021265890590) #### DEA Schedule III Rescheduling: What Actually Changes for Patients Moving from Schedule I to Schedule III: dissecting FDA medical acceptance, pharmaceutical clinical trials, and tax implications under 280E. [♬ Watch on TikTok ↗](https://www.tiktok.com/@drbenjamincaplan/video/7577237021265890590) [▶ YouTube Short ↗](https://www.youtube.com/shorts/Q-UTSirygX8) --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).